Christos Chasapis

Dr. Christos Chasapis

University of Patras
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2011 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
CCChristos Chasapis
Christos Chasapis
ALAriadni C. Loutsidou
Ariadni C. Loutsidou
CSChara Spiliopoulou
Chara Spiliopoulou
MSMaria E. Stefanidou
Maria E. Stefanidou

12 May 2020 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
CCChristos Chasapis
Christos Chasapis
PNPanagoula-Stamatina A. Ntoupa
Panagoula-Stamatina A. Ntoupa
CSChara A. Spiliopoulou
Chara A. Spiliopoulou
MSMaria E. Stefanidou
Maria E. Stefanidou

27 May 2013 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
AAAntonia Asimakopoulou
Antonia Asimakopoulou
PPPanagiotis Panopoulos
Panagiotis Panopoulos
CCChristos Chasapis
Christos Chasapis
CCCiro Coletta
Ciro Coletta
ZZZongmin Zhou
Zongmin Zhou
Andreas PapapetropoulosAndreas Papapetropoulos
Andreas Papapetropoulos
Background and Purpose: Hydrogen sulfide ( H2S ) is a signalling molecule that belongs to the gasotransmitter family. Two major sources for endogenous enzymatic production of H2S are cystathionine β synthase (CBS) and cystathionine γ lyase (CSE). In the present study, we examined the selectivity of commonly used pharmacological inhibitors of H2S biosynthesis towards CSE and CBS.Experimental Approach: To address this question, human CSE or CBS enzymes were expressed and purified from Escherichia coli as fusion proteins with GSH‐S‐transferase. After purification, the activity of the recombinant enzymes was tested using the methylene blue method.Key Results: β‐cyanoalanine (BCA) was more potent in inhibiting CSE than propargylglycine (PAG) (IC50 14 ± 0.2 μM vs. 40 ± 8 μM respectively). Similar to PAG, L‐aminoethoxyvinylglycine (AVG) only inhibited CSE, but did so at much lower concentrations. On the other hand, aminooxyacetic acid (AOAA), a frequently used CBS inhibitor, was more potent in inhibiting CSE compared with BCA and PAG (IC50 1.1 ± 0.1 μM); the IC50 for AOAA for inhibiting CBS was 8.5 ± 0.7 μM. In line with our biochemical observations, relaxation to L‐cysteine was blocked by AOAA in aortic rings that lacked CBS expression. Trifluoroalanine and hydroxylamine, two compounds that have also been used to block H2S biosynthesis, blocked the activity of CBS and CSE. Trifluoroalanine had a fourfold lower IC50 for CBS versus CSE, while hydroxylamine was 60‐fold more selective against CSE.Conclusions and Implications: In conclusion, although PAG, AVG and BCA exhibit selectivity in inhibiting CSE versus CBS, no selective pharmacological CBS inhibitor is currently available.

24 December 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
Massimiliano F PeanaMassimiliano F Peana
Massimiliano F Peana
APAlessio Pelucelli
Alessio Pelucelli
CCChristos Chasapis
Christos Chasapis
Spyros PerlepesSpyros Perlepes
Spyros Perlepes
VBVlasoula Bekiari
Vlasoula Bekiari
MZMaria Antonietta Zoroddu
Maria Antonietta Zoroddu
Cadmium (Cd) is a toxic metal for the human organism and for all ecosystems. Cd is naturally found at low levels; however, higher amounts of Cd in the environment result from human activities as it spreads into the air and water in the form of micropollutants as a consequence of industrial processes, pollution, waste incineration, and electronic waste recycling. The human body has a limited ability to respond to Cd exposure since the metal does not undergo metabolic degradation into less toxic species and is only poorly excreted. The extremely long biological half-life of Cd essentially makes it a cumulative toxin; chronic exposure causes harmful effects from the metal stored in the organs. The present paper considers exposure and potential health concerns due to environmental cadmium. Exposure to Cd compounds is primarily associated with an elevated risk of lung, kidney, prostate, and pancreatic cancer. Cd has also been linked to cancers of the breast, urinary system, and bladder. The multiple mechanisms of Cd-induced carcinogenesis include oxidative stress with the inhibition of antioxidant enzymes, the promotion of lipid peroxidation, and interference with DNA repair systems. Cd2+ can also replace essential metal ions, including redox-active ones. A total of 12 cancer types associated with specific genes coding for the Cd-metalloproteome were identified in this work. In addition, we summarize the proper treatments of Cd poisoning, based on the use of selected Cd detoxifying agents and chelators, and the potential for preventive approaches to counteract its chronic exposure.

19 April 2021 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
Massimiliano F PeanaMassimiliano F Peana
Massimiliano F Peana
SMSerenella Medici
Serenella Medici
Maryam DadarMaryam Dadar
Maryam Dadar
MZMaria Antonietta Zoroddu
Maria Antonietta Zoroddu
APAlessio Pelucelli
Alessio Pelucelli
Geir BjørklundGeir Bjørklund
Geir Bjørklund

1 January 2023
Verified
Journal Article
Open access
DKDespoina P. Kiouri
Despoina P. Kiouri
ETEvi Tsoupra
Evi Tsoupra
MPMassimiliano Peana
Massimiliano Peana
SPSpyros P. Perlepes
Spyros P. Perlepes
MSMaria E. Stefanidou
Maria E. Stefanidou
CCChristos Chasapis
Christos Chasapis
Zinc is a multipurpose trace element for the human body, as it plays a crucial part in various physiological processes, such as cell growth and development, metabolism, cognitive, reproductive, and immune system function. Its significance in human health is widely acknowledged, and this has led the scientific community towards more research that aims to uncover all of its beneficial properties, especially when compared to other essential metal ions. One notable area where zinc has shown beneficial effects is in the prevention and treatment of various diseases, including cancer. This review aims to explain the involvement of zinc in specific health conditions such as cancer, coronavirus disease 2019 (COVID-19) and neurological disorders like Alzheimer's disease, as well as its impact on the gut microbiome.